Search

Your search keyword '"Rossini, Paolo"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Rossini, Paolo" Remove constraint Author: "Rossini, Paolo" Journal alzheimer's & dementia: the journal of the alzheimer's association Remove constraint Journal: alzheimer's & dementia: the journal of the alzheimer's association
41 results on '"Rossini, Paolo"'

Search Results

1. Cognitive resilience/reserve: Myth or reality? A review of definitions and measurement methods.

2. FDG‐PET markers of heterogeneity and different risk of progression in amnestic MCI.

3. Global estimates on the number of persons across the Alzheimer's disease continuum.

4. Early dementia diagnosis, MCI‐to‐dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.

7. ROLE OF THE INFLAMMASOME COMPLEX IN AD-RELATED HIPPOCAMPAL NEURODEGENERATION IN MCI PATIENTS WITH AD PATHOLOGY

8. BLOOD INFLAMMATORY PROFILES MEASURED BY THE ADFLAG® TEST ENABLE STRATIFICATION OF PRE-DEMENTIA ALZHEIMER’S DISEASE

9. VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION

10. PREDICTING AND MONITORING SHORT-TERM DISEASE PROGRESSION IN A-MCI PATIENTS WITH PRODROMAL AD USING MRI STRUCTURAL BRAIN BIOMARKERS

11. Aβ/PHOSPHO TAU LOAD IN CSF IS RELATED TO CORTICAL EXCITABILITY AS REVEALED BY CORTICAL EEG BIOMARKERS IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE: THE PHARMACOG PROJECT

12. ADFLAG®, A DIAGNOSTIC BLOOD TEST FOR PRE-DEMENTIA STAGES OF ALZHEIMER’S DISEASE

13. ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY

14. BIOMARKERS OF SHORT TERM DISEASE PROGRESSION IN MILD COGNITIVE IMPAIRMENT PATIENTS WITH AD PATHOLOGY

15. ASSOCIATION BETWEEN VOLUME ALTERATIONS AND CSF BIOMARKERS IN AMNESTIC MCI

16. DIFFERENTIAL EFFECTS OF APOE AND CSF AMYLOID ON MEMORY IMPAIRMENT IN INDIVIDUALS WITH AMNESTIC MCI USING THE CANTAB COGNITIVE BATTERY: RESULTS FROM THE EUROPEAN-ADNI STUDY

17. ASSOCIATION BETWEEN BRAIN MRI DIFFUSION ALTERATIONS AND CSF BIOMARKERS IN AMNESTIC MCI

18. ASSOCIATION BETWEEN EEG/ERP AND CSF MARKERS IN PRODROMAL ALZHEIMER’S DISEASE IN THE PHARMACOG PROJECT

19. BACK-TRANSLATION OF EEG/ERP MARKERS FROM AMNESTIC MCI PATIENTS TO HEALTHY YOUNG VOLUNTEERS IN THE PHARMACOG PROJECT

20. CSF BETA-AMYLOID- AND APOE Ɛ4-RELATED DECLINE IN EPISODIC MEMORY OVER 12 MONTHS MEASURED USING THE CANTAB IN INDIVIDUALS WITH AMNESTIC MCI: RESULTS FROM THE EUROPEAN ADNI STUDY

21. A short computerized cognitive training may affect cortical sources of rsEEG rhythms in Alzheimer's disease patients.

23. P4‐077: BLOOD INFLAMMATORY PROFILES MEASURED BY THE ADFLAG® TEST ENABLE STRATIFICATION OF PRE‐DEMENTIA ALZHEIMER'S DISEASE.

24. O1‐13‐01: ROLE OF THE INFLAMMASOME COMPLEX IN AD‐RELATED HIPPOCAMPAL NEURODEGENERATION IN MCI PATIENTS WITH AD PATHOLOGY.

28. P3‐368: PREDICTING AND MONITORING SHORT‐TERM DISEASE PROGRESSION IN A‐MCI PATIENTS WITH PRODROMAL AD USING MRI STRUCTURAL BRAIN BIOMARKERS.

29. P2‐101: Aβ/PHOSPHO TAU LOAD IN CSF IS RELATED TO CORTICAL EXCITABILITY AS REVEALED BY CORTICAL EEG BIOMARKERS IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE: THE PHARMACOG PROJECT.

30. BACK-TRANSLATION OF EEG/ERP MARKERS FROM AMNESTIC MCI PATIENTS TO HEALTHY YOUNG VOLUNTEERS IN THE PHARMACOG PROJECT.

31. CSF BIOMARKERS AND EFFECT OF APOLIPOPROTEIN E GENOTYPE, AGE AND SEX ON CUT-OFF DERIVATION IN MILD COGNITIVE IMPAIRMENT.

32. STRUCTURAL AND DIFFUSION TENSOR IMAGING IN MCI SUBJECTS WITH INTERMEDIATE RISK OF ALZHEIMER’S DISEASE BASED ON CSF PROFILE.

33. COGNITIVE COMPOSITE MEASURES IN AMNESTIC MCI BY DIFFERENT AMYLOID/TAU PATHOLOGY.

34. IMPAIRMENT OF RESTING-STATE FUNCTIONAL CONNECTIVITY IN THE DEFAULT-MODE NETWORK CLOSELY TRACKS CSF BIOMARKERS IN MCI.

35. Are cortical sources of auditory oddball event-related potentials an early diagnostic marker of Alzheimer’s disease?

38. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study.

39. Multisite hippocampal subfields reproducibility: A european 3T study.

40. Are cortical sources of resting state eyes-closed electroencephalographic rhythms an early diagnostic marker of Alzheimer's disease?

41. Multi-site hippocampal subfields reproducibility: A european 3T study.

Catalog

Books, media, physical & digital resources